SMO and hepatocellular carcinoma: As shown in Figure S1A, a number of stemness-related genes, including Nanog, Notch1, OCT4, and SMO, showed a tendency toward downregulation in all 15d-PGJ2-treated cells, indicating that PPARγ agonists may have an effect on HCC TICs.